Fusion Pharmaceuticals Inc

Fusion Pharmaceuticals Receives Final Court Order Approving ...

HAMILTON, ON and BOSTON, May 31, 2024/ PRNewswire/-- Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing ...

Canada's Fusion Pharmaceuticals files for $100M US IPO

Hamilton, Ontario-based Fusion Pharmaceuticals Inc. is planning to list its shares on the Nasdaq Global Market under the ticker symbol FUSN.

Acquisition of Fusion Pharmaceuticals Completed - BioSpace

Fusion Pharmaceuticals Inc. announced the successful completion of the acquisition of all of the issued and outstanding shares of Fusion by a wholly-owned ...

Fusion Pharmaceuticals - Osler, Hoskin & Harcourt LLP

Each of Adams Street Partners, Seroba Life Sciences and Varian Medical Systems Inc. participated in the second closing, as new investors, and TPG Biotech and ...

Fusion Pharmaceuticals to be Acquired by AstraZeneca ... - Stock Titan

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) to be acquired by AstraZeneca in a $2.4 billion transaction. Fusion's radioconjugate targeting ...

Fusion Pharmaceuticals Shareholders Approve Acquisition by ...

CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates ...

Fusion Pharmaceuticals to acquire phase 2 program for 225Ac ...

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) (“Fusion”), a clinical-stage oncology company focused on developing next-generation targeted ...

Astra to Buy Fusion Pharma in Hunt for New Cancer Treatments

AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as European drugmakers snap up promising biotech ...

What is the current valuation of Fusion Pharmaceuticals's FPI-1434

Fusion Pharmaceuticals Inc · View all. The revenue for FPI-1434 is expected to reach an annual total of $70 mn by 2039 in the US based off ...

Stock Price, Institutional Ownership, Shareholders (NasdaqGS) - Fintel

Fusion Pharmaceuticals Inc. (US:FUSN) has 25 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission ( ...

Fusion Pharmaceuticals Opens Radiopharmaceutical Manufacturing ...

Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines ...

Options Markets - Delisting of Fusion Pharmaceuticals Inc. (FUSN)

Fusion Pharmaceuticals Inc. (FUSN) will be de-listed from the MIAX Options Exchange, MIAX Pearl Options Exchange and MIAX Emerald Options ...

Fusion Pharmaceuticals Inc. Number of Employees 2020-2024 | FUSN

Fusion Pharmaceuticals Inc. number of employees from 2020 to 2024. Number of employees can be defined as a measure of financial performance calculated as ...

FPX-01(Fusion Pharmaceuticals, Inc.) - Patsnap Synapse

FPX-01(Fusion Pharmaceuticals, Inc.): a IGF-1R modulators Drug, Initially developed by Fusion Pharmaceuticals, Inc., Now, its global highest R&D status is ...

Fusion Pharma - Aiming For A Precise Target - RTTNews

Shares of Fusion Pharmaceuticals Inc. (FUSN) have more than halved from their 52-week high of $18.50, recorded last June, to trade around $8 ...

Fusion Pharmaceuticals Announces Nomination Of First Targeted ...

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as ...

TRIUMF and Fusion Pharmaceuticals announce expanded R&D ...

TRIUMF and Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines,

Fusion Pharmaceuticals Announces $105-Million Financing

Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, ...

Fusion Pharmaceuticals to Present at the Guggenheim Securities ...

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.

Fusion Pharmaceuticals and BWXT Medical Announce Actinium ...

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.